Acute myeloid leukemia aml is a hematologic disorder originating from a malignant clone of myeloid primitive cells. Acute myeloid leukemia aml is often caused by radiation, drugs, viruses, etc., and its classification can be divided into M0-M7. Clinical manifestations often include fever, anemia, hemorrhage, infiltration such as green tumors, and sternal pressure pain. Its treatment mainly consists of chemotherapy such as zorubicin, cytarabine, all-trans retinoic acid, etc., which can be combined with targeted drugs such as gitolizumab, and surgical treatment such as allogeneic stem cell transplantation. The average survival of acute leukemia patients without active treatment is about 3 months, and active treatment can make some patients survive for a long time. Patients with acute myeloid leukemia should go to the hospital for further examination and treatment under the guidance of professional doctors if they have any uncomfortable symptoms, and medications should be used under the guidance of doctors.